Skip to main content

ziprasidone mesylate

NDC 68083-340 · Gland Pharma Limited

Generic nameziprasidone mesylate
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAMUSCULAR
Active ingredient(s)ZIPRASIDONE MESYLATE
Strength20 mg/mL
Pharmacologic classAtypical Antipsychotic [EPC]
Marketing categoryANDA

Packages

68083-340-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-340-01) / 1 mL in 1 VIAL, SINGLE-DOSE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0049-3920 — ziprasidone mesylate, 43598-061 — ziprasidone mesylate, 43598-848 — ziprasidone mesylate, 51662-1564 — ZIPRASIDONE MESYLATE, 58151-137 — ziprasidone mesylate, 72205-205 — ziprasidone mesylate, 72266-160 — Ziprasidone Mesylate, 82449-004 — ziprasidone mesylate

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources